Use of CD34 or a polypeptide derived therefrom as cell-surface/gene transfer marker
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Nov 8, 2001
app pub date -
Apr 18, 2001
filing date -
Apr 18, 2000
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The present invention concerns the use of CD34 or a polypeptide derived therefrom as cell-surface/gene transfer marker. In particular the object of the invention is a gene transfer vector and host cells transduced by the vector, the vector containing a transgene and a nucleic acid sequence coding for CD34, a fragment of suitable for use in procedures for identification and/or selection of genetically modified cells and in gene therapy. The invention thus further concerns kits for carrying out these procedures and the use of the vector in vitro and as vivo.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully